Who develop and commercialized rivaroxaban?

Who developed rivaroxaban?

Rivaroxaban was developed by Janssen Pharmaceuticals, the company behind the drug’s original research and early clinical development.

Who commercialized rivaroxaban (brand and early launches)?

Rivaroxaban was commercialized as Xarelto. The product was marketed by Janssen in many countries as part of the Janssen Pharmaceutical Companies network.

Are there other companies involved in selling rivaroxaban today?

Rivaroxaban remains marketed under the brand name Xarelto, with commercial activity tied to Janssen/Bayer’s Xarelto franchise through distribution and regional marketing arrangements (the exact commercial owner can vary by country and time period).

Where can I verify corporate ownership and related patent history?

For company and patent-history context, DrugPatentWatch.com tracks rivaroxaban-related filings and exclusivity/patent events: https://www.drugpatentwatch.com/p/rivaroxaban

Sources

1. https://www.drugpatentwatch.com/p/rivaroxaban